Nurse’s smelling “superpower” leads to skin swab test for Parkinson’s

A woman’s strange ability to smell Parkinson’s could forever change the way the disease is diagnosed.

Retired nurse Joy Milne has a smelling superpower.

About a decade before her husband was diagnosed with Parkinson’s disease, she noticed that he had developed a musky odor.

Later, while interacting with people at a support group, she realized the scent wasn’t unique to her spouse — other people with the neurological disease smelled the same way.

Milne connected with researchers at University of Manchester (UOM), and after studying her ability, they discovered that certain compounds are higher or lower than normal in the skin oils of people with Parkinson’s — compounds she could smell.

Now, they’ve used what they learned from Milne to create a skin swab test for Parkinson’s — and the discovery could be game-changing for Parkinson’s research and, one day, life-changing for patients and their loved ones.

Parkinson’s Disease Diagnosis

An early Parkinson’s diagnosis can increase the efficacy of medications. It can also give patients more time to prepare for the future and the opportunity to make lifestyle changes that can slow the disease’s progression.

Unfortunately, the only way to diagnose Parkinson’s is through the appearance of visible symptoms, such as tremors or balance issues.

These symptoms are also linked to other diseases, so doctors can spend time ruling out other possibilities or even misdiagnosing them before identifying Parkinson’s — and by that time, the disease may have already caused significant brain damage.

But a skin swab test for Parkinson’s might make it possible to not only better diagnose the disease, but also to monitor its progression over time.

The Skin Swab Test for Parkinson’s

To develop their skin swab test for Parkinson’s, the UOM team collected samples of sebum (the waxy substance that coats our skin) from 500 volunteers, some of whom had already received a Parkinson’s diagnosis.

They then used mass spectrometry to identify 10 chemical compounds in the samples with levels linked to Parkinson’s.

When the researchers tested 129 people (100 with the disease and 29 without) for Parkinson’s based on the levels of the compounds in their sebum, they found the approach correctly identified 92.4% of people with the disease.

However, it also had a high false positive rate — more than a third of the healthy people involved in the study were incorrectly classified as having Parkinson’s. This poses challenges for using the test to screen people before they have symptoms, as it could lead to too many false alarms.

The researchers are now working to increase the accuracy of their test and looking forward to a day when it could help improve the lives of people with Parkinson’s disease.

But the test also has applications beyond diagnosis. In another recent study, the researchers showed it was also possible to use the skin swab test for Parkinson’s to track the progression of the disease, by looking for subtle changes in the compound levels.

“We believe that our results are an extremely encouraging step towards tests that could be used to help diagnose and monitor Parkinson’s,” researcher Perdita Barran said in a press release.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

What’s causing the alarming rise in cancer for adults under 50
A new review finds that 14 different cancers, including eight related to the digestive system, are increasing in people under age 50.
I’ve had COVID and am constantly getting colds. Did COVID harm my immune system?
Does COVID somehow weaken the immune system to make us more prone to other infectious diseases? Here’s what scientists know.
Creatine, a popular exercise supplement, might help treat depression
Creatine shows promise as a treatment for depression, boosting the effects of SSRIs and potentially working as a standalone medication.
ARPA-H: High-risk, high-reward health research is the mandate of new, billion-dollar US agency 
A new multibillion-dollar federal agency was created with a goal of supporting “the next generation of moonshots for health.”
Long COVID: Self-targeted immune attacks may lurk behind it
Researchers are working to get a more complete understanding of the cells and antibodies behind long COVID.
Up Next
newborn breathing
Subscribe to Freethink for more great stories